SCHEMBL6809832

SCHEMBL6809832

CC(COc1ccccc1)NC=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.61
PTGS1 P23219 1/20 0.61
MTNR1A P48039 3/20 0.58
MTNR1B P49286 3/20 0.58
MEN1 O00255 3/20 0.56
KMT2A Q03164 3/20 0.56
TAAR1 Q96RJ0 1/20 0.56
LMNA P02545 1/20 0.52
CYP2D6 P10635 2/20 0.46
ADRB2 P07550 1/20 0.46
ADRB1 P08588 1/20 0.46
ADRB3 P13945 1/20 0.46
HIF1A Q16665 2/20 0.46
ALDH1A1 P00352 1/20 0.46
CYP1A2 P05177 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
DRD1 P21728 1/20 0.46
SLC6A2 P23975 1/20 0.46
SLC6A4 P31645 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6809826 1.00 MAOA (0.61) MAOAPTGS1MTNR1AMTNR1BMEN1
SCHEMBL21547285 0.82 MAPK1 (0.53) MTNR1AMTNR1BKMT2AMAPK1
SCHEMBL13212031 0.77 MAOA (0.69) MAOAPTGS1MTNR1AMTNR1BMEN1
SCHEMBL11598862 0.77 MAOA (0.69) MAOAPTGS1MTNR1AMTNR1BMEN1
SCHEMBL3961897 0.76 SCN4A (0.54) MAOAMEN1KMT2ATAAR1LMNA
SCHEMBL13996939 0.76 MAOA (0.67) MAOAPTGS1MTNR1AMTNR1BMEN1
SCHEMBL96547 0.76 LMNA (0.57) MAOAPTGS1MTNR1AMTNR1BMEN1
SCHEMBL11573929 0.76 CYP2D6 (0.67) PTGS1MEN1KMT2ACYP2D6ADRB2
Phenoxypropazine SCHEMBL147198 0.76 MAOA (1.00) MAOAPTGS1MTNR1AMTNR1BMEN1
Phenoxypropazine SCHEMBL4034660 0.74 MAOA (0.96) MAOAPTGS1MTNR1AMTNR1BMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040106653-A1 Aminoalcohol derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-06-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040106653-A1 Aminoalcohol derivatives FANCD2, FANCI, HRH2 MAOA 3774/4885PTGS1 1789/4885MTNR1A 1674/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.